Baseline Characteristics Module
The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.
Baseline Characteristics Module path is as follows:
Study -> Results Section -> Baseline Characteristics Module
Baseline Characteristics Module
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-25 @ 2:08 PM
NCT ID:
NCT03596866
Population Description:
Full Analysis Set(FAS) included all participants randomized to each regimen regardless of whether they were ALK+ by an Food and Drug Administration(FDA) approved test (Vysis ALK Break Apart fluorescence in situ hybridization(FISH) Probe Kit, Ventana ALK (D5F3) Companion Diagnostics (CDx) Assay, Foundation Medicine's FoundationOne CDx) or a local test other than FISH and immunohistochemistry, or whether they received study drug or adhered to the assigned dose.
Study:
NCT03596866
Study Brief:
Results Section:
NCT03596866